PMID- 32395809
OWN - NLM
STAT- MEDLINE
DCOM- 20201001
LR  - 20201001
IS  - 2724-7031 (Electronic)
IS  - 0041-4131 (Linking)
VI  - 98
IP  - 2
DP  - 2020 Feb
TI  - Mammary analogue secretory carcinoma: A case report.
PG  - 168-171
AB  - BACKGROUND: Mammary analogue secretory carcinoma is a rare new entity of 
      low-grade malignant tumor of salivary glands. It shared the same histologic 
      features and the chromosomal translocation t(12;15)(p13;q25) as secretory 
      carcinoma of the breast. AIM: To highlight the diagnosis approaches and the 
      attitude of management in a case of MASC which is the first case reported in 
      Tunisia. Reported case: A case of MASC of the lower left jugal mucosa was 
      reviewed for its microscopic and immunohistochemical features. Fluorescence in 
      situ hybridization (FISH) for the ETV6-NTRK3 translocation was performed. Surgery 
      was the only treatment required in this case. No signs of local or regional 
      recurrence during the one-year follow-up were noticed. COMMENTARIES: Secretory 
      carcinoma was confused with other salivary gland tumors especially acinic cell 
      carcinoma due to their morphological similarities, making diagnosis dilemma. 
      Fluorescence in-situ hybridization (FISH) is the one definitive finding to 
      confirm the diagnosis of MASC and to differentiate it from the other types of 
      salivary gland tumor. At the present time, no specific therapy is available for 
      patients with MASC.
FAU - Hedhli, Fatma
AU  - Hedhli F
FAU - Ouertani, Hend
AU  - Ouertani H
FAU - Gargouri, Faten
AU  - Gargouri F
FAU - Naija, Sonia
AU  - Naija S
FAU - Casiraghi, Odile
AU  - Casiraghi O
FAU - Valent, Alexander
AU  - Valent A
FAU - Khatteche, Bassem
AU  - Khatteche B
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Tunisia
TA  - Tunis Med
JT  - La Tunisie medicale
JID - 0413766
RN  - 0 (ANO1 protein, human)
RN  - 0 (Anoctamin-1)
RN  - 0 (ETV6-NTRK3 fusion protein, human)
RN  - 0 (Mammaglobin A)
RN  - 0 (Neoplasm Proteins)
RN  - 0 (Oncogene Proteins, Fusion)
RN  - 0 (S100 Proteins)
SB  - IM
MH  - Anoctamin-1/analysis/metabolism
MH  - Cheek/pathology
MH  - Cytogenetic Analysis
MH  - Diagnosis, Differential
MH  - Female
MH  - Humans
MH  - Immunohistochemistry
MH  - In Situ Hybridization, Fluorescence
MH  - Mammaglobin A/analysis/metabolism
MH  - Mammary Analogue Secretory Carcinoma/*diagnosis/genetics/surgery
MH  - Mouth Mucosa/metabolism/pathology
MH  - Neoplasm Proteins/analysis/metabolism
MH  - Oncogene Proteins, Fusion/analysis/genetics
MH  - S100 Proteins/analysis/metabolism
MH  - Tunisia
EDAT- 2020/05/13 06:00
MHDA- 2020/10/02 06:00
CRDT- 2020/05/13 06:00
PHST- 2020/05/13 06:00 [entrez]
PHST- 2020/05/13 06:00 [pubmed]
PHST- 2020/10/02 06:00 [medline]
AID - /article-medicale-tunisie.php?article=3692 [pii]
PST - ppublish
SO  - Tunis Med. 2020 Feb;98(2):168-171.